Assessing the value of novel therapies has been challenging and controversial using existing methods, pointing to the need for continued exploration of new approaches.
Innovation and Value Initiative
Advertisement
Articles by Innovation and Value Initiative
Advertisement
Latest Updated Articles
- For Cell and Gene Therapies, MCDA Holds Promise for Improving Equity in Value Assessment
Published: July 26th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
2
Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks
3
CGTLive®’s Weekly Rewind – October 17, 2025
4
